HER2, EGFRvIII, and IL13‐R2 can be regarded as safe and efficient targets for CAR therapy in the treatment of glioblastoma, according to the results of trials completed and published so far.103, 104, 105, 106. Here, ERBB2 is linked to glioblastoma.